New Delhi, Jan 6 (IANS) The Indian Medical Association (IMA) Tuesday expressed concern over a recent survey which showed that 44 percent of surgeries advised to patients by doctors were not needed.
In a letter to the Medical Council of India and Maharashtra Medical Council, the IMA said: "If the findings of this survey are correct, it is a matter of national concern but if the findings of this survey are not correct, it will cause a great damage to doctor-patient relationship".
The survey, with a data base of 12,500 patients, showed that over 44 percent of the surgeries were advised needlessly.
According to IMA officials, the second opinions which the survey quoted were given via e-mail and as per IMA guidelines, difference of opinion is not negligence and second opinion of a single doctor would only amount to difference of opinion.
"By IMA definition, the second opinion is always a peer review which must have an opinion of two or three more doctors in consultation," IMA national president A. Marthanda Pillai and honorary secretary general K. K. Aggarwal said in a joint statement.
"Various Supreme Court judgments have shown error judgments and difference of opinion is not a professional misconduct or negligence," the statement said.
Prabhu connects Bengaluru to Vaishno Devi Shrine
Bengaluru, Jan 29 (IANS) Railway Minister Suresh Prabhakar Prabhu Thursday flagged off a premium train here connecting India's tech hub to Katra town, 13km from Mata Vaishno Devi shrine in Jammu
Over 10 Percent Growth in Foreign Tourist Arrivals
New Delhi, March 9 (IANS) Foreign tourist arrivals grew by 10.6 percent in 2014 as compared to last year, the tourism ministry said on Monday."The yearly estimate of FTA (foreign tourist arrivals)
Indo-China border dispute / Divisional commander level talks between the two countries today; Rahul said- Chinese entered our border, but the Prime Minister is silent
Ladakh Divisional commander-level talks of the two countries' armies will take place today, with signs of easing tensions between India and China on the Line of Actual Control (LAC) near eastern
Congress disapproves Sibal representing Mamata Government in court
Kolkata, Jan 21 (IANS) The Congress central leadership has disapproved senior party leader Kapil Sibal representing the West Bengal government in a petition in the Supreme Court concerning the CBI
91 thousand patients increased within 24 hours, a record more than 82 thousand people were also cured; 82 thousand 91 deaths so far
The number of corona patients in the country crossed 50 lakhs. So far 50 lakh 18 thousand 34 people have been found infected. 91 thousand 96 new patients increased within the last 24 hours. It is a
India-China Border: indo-Pak Army maneuvers continue in Tibet across LAC, Indian Army also increased vigil
China and Pakistan have once again started their war preparations under the guise of normalizing the situation in the border areas with India. These days the Air Force of China and Pakistan are
Both need a victory to stay in the tournament, Rajasthan sixth and Hyderabad at number 7
The 40th match of the 13th season of IPL will be played between Rajasthan Royals (RR) and Sunrisers Hyderabad (SRH) in Dubai from 7:30 pm. Both teams must win this match to stay in the tournament. In
Chandrayaan 3 Landing: At what speed will Chandrayaan-3 land on the moon… understand what the lander and rover will do
Chandrayaan 3 Mission: Four years after the failed Chandrayaan 2, Chandrayaan 3 will make its soft landing on the surface of the Moon on Wednesday (August 23) at 6.4 pm.
Haryana government announced after increasing lockdown, financial assistance of Rs 5000 to poor families
Amid restrictions imposed to prevent corona infection, the Haryana government has made a big announcement to help families living below the poverty line. The Manohar Lal Khattar government of the
AstraZeneca's claim even after the Oxford vaccine's trials stop - this year the vaccine will come
A group of experts have started investigating the health of a Volunteer during clinical trials of the Covid-19 vaccine at Oxford University and AstraZeneca. Even though this development has slowed the
